Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Gonadotropin peptide (substance) |
Is a |
True |
Gonadotropin |
Inferred relationship |
Some |
|
Pituitary gonadotropin |
Is a |
True |
Gonadotropin |
Inferred relationship |
Some |
|
Human chorionic gonadotropin |
Is a |
False |
Gonadotropin |
Inferred relationship |
Some |
|
Product containing choriogonadotropin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Some |
|
choriogonadotropin alfa 1500 IE pulver og solvens til injektionsvæske, opløsning, ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Some |
|
choriogonadotropin alfa 2000 IE pulver og solvens til injektionsvæske, opløsning, ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Some |
|
choriogonadotropin alfa 5000 IE pulver og solvens til injektionsvæske, opløsning, ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Some |
|
choriogonadotropin alfa 10.000 IE pulver og solvens til injektionsvæske, opløsning, ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Some |
|
Product containing recombinant human chorionic gonadotrophin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Some |
|
Urofollitropin (substance) |
Is a |
True |
Gonadotropin |
Inferred relationship |
Some |
|
gonadotropinpræparat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Some |
|
humane menopausale gonadotropiner |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Some |
|
humane menopausale gonadotropiner 75 enheder (FSH) pulver og solvent til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Some |
|
Human menopausal gonadotrophins 75iu injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Some |
|
Human menopausal gonadotrophins 150iu injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Some |
|
humane menopausale gonadotropiner 150 enheder (FSH) pulver til injektionsvæske, rekonstitution + solvent |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Some |
|
Human menopausal gonadotrophins 75iu injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Some |
|
Human menopausal gonadotrophins 150iu injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Some |
|
Choriogonadotropin (substance) |
Is a |
True |
Gonadotropin |
Inferred relationship |
Some |
|
gonadotropinudløsende hormon-analog |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Some |
|
Product containing gonadotropin releasing hormone receptor antagonist (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Some |
|
Accidental gonadotrophin poisoning |
Causative agent |
True |
Gonadotropin |
Inferred relationship |
Some |
1 |
Intentional gonadotrophin poisoning |
Causative agent |
True |
Gonadotropin |
Inferred relationship |
Some |
1 |
forgiftning med gonadotropin, uvist med hvilken hensigt |
Causative agent |
False |
Gonadotropin |
Inferred relationship |
Some |
1 |
Gonadotrophic hormone adverse reaction |
Causative agent |
True |
Gonadotropin |
Inferred relationship |
Some |
1 |
Allergy to gonadotropin |
Causative agent |
False |
Gonadotropin |
Inferred relationship |
Some |
|
Product containing gonadorelin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Some |
|
Nafarelin (as nafarelin acetate) 200 microgram/actuation nasal spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Some |
|
Product containing ganirelix (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Some |
|
ganirelix 500 µg/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 0,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Some |
|
Product containing buserelin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Some |
|
buserelin 1 mg/ml injektionsvæske, opløsning, hætteglas a 5,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Some |
|
Buserelin (as buserelin acetate) 100 microgram/actuation nasal spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Some |
|
Product containing precisely goserelin (as goserelin acetate) 3.6 milligram/1 each prolonged-release subcutaneous implant (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Some |
|
Product containing precisely goserelin (as goserelin acetate) 10.8 milligram/1 each prolonged-release subcutaneous implant (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Some |
|
leuprorelinacetat 3,75 mg pulver til injektionsvæske, rekonstitution, + diluent + sæt |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Some |
|
leuprorelinacetat 11,25 mg pulver til injektionsvæske, opløsning, rekonstitution + diluent |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Some |
|
Product containing triptorelin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Some |
|
triptorelin 4,2 mg pulver og solvens til injektionsvæske, suspension, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Some |
|
gonadotropt hormon |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Some |
|
Product containing leuprorelin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Some |
|
buserelin 150 µg spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Some |
|
histrelin 50 mg implantat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Some |
|
leuprorelinacetat 45 mg pulver til injektionsvæske, suspension, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Some |
|
Product containing goserelin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Some |
|
goserelinacetatpræparat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Some |
|
Product containing nafarelin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Some |
|
nafarelinacetatpræparat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Some |
|
Product containing histrelin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Some |
|
histrelinacetatpræparat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Some |
|
gonadorelinacetatpræparat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Some |
|
gonadorelinhydrochloridpræparat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Some |
|
Product containing gonadotropin releasing factor (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Some |
|
Poisoning by gonadotropin |
Causative agent |
True |
Gonadotropin |
Inferred relationship |
Some |
1 |
leuprorelinacetat 65 mg implantat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Some |
|
triptorelin 3,75 mg pulver og solvens til injektionsvæskei fyldt injektionssprøjte |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Some |
|
triptorelin 15 mg pulver og diluent til injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Some |
|
Buserelin acetate [endometriosis] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Some |
|
leuprorelinacetat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Some |
|
Gonadotrophin release hormone |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Some |
|
Product containing abarelix (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Some |
|
abarelix 100 mg pulver til injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Some |
|
goserelinacetat implantat, i fyldt injektionssprøjte a 10,8 mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Some |
|
triptorelinpamoat 3,75 mg hætteglas pulver |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Some |
|
triptorelinpamoat 11,25 mg hætteglas pulver |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Some |
|
leuprorelinacetat 15 mg pulver og solvens til injektionsvæske, suspension, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Some |
|
leuprorelinacetat 5 mg/ml injektionsvæske, opløsning, ampul a 0,2 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Some |
|
leuprorelinacetat 3,75 mg hætteglas pulver |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Some |
|
leuprorelinacetat 7,5 mg pulver til injektionsvæske, suspension, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Some |
|
leuprorelinacetat 22,5 mg pulver til injektionsvæske, suspension, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Some |
|
leuprorelinacetat 30 mg pulver til injektionsvæske, suspension, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Some |
|
leuprorelinacetat 11,25 mg pulver til injektionsvæske, suspension, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Some |
|
gonadorelinhydrochlorid 100 µg pulver og solvent til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Some |
|
goserelinacetat 3,6 mg implantat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Some |
|
histrelin 120 µg/0,6 ml (200 µg/ml peptidbase) injektionsvæske, opløsning, hætteglas a 0,6 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Some |
|
histrelin 600 µg/0,6 ml (1000 µg/ml peptidbase) injektionsvæske, opløsning, hætteglas a 0,6 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Some |
|
histrelin 300 µg/0,6 ml (500 µg/ml peptidbase) injektionsvæske, opløsning, hætteglas a 0,6 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Gonadotropin |
Inferred relationship |
Some |
|
Allergy to gonadotropin |
Causative agent |
True |
Gonadotropin |
Inferred relationship |
Some |
1 |
Follitropin alfa (substance) |
Is a |
False |
Gonadotropin |
Inferred relationship |
Some |
|
follitropin beta |
Is a |
False |
Gonadotropin |
Inferred relationship |
Some |
|
Lutropin alfa |
Is a |
False |
Gonadotropin |
Inferred relationship |
Some |
|
Recombinant human chorionic gonadotrophin (substance) |
Is a |
False |
Gonadotropin |
Inferred relationship |
Some |
|
Gonadotropin-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Gonadotropin |
Inferred relationship |
Some |
1 |